Tyloxapol: Difference between revisions
CSV import |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
== Tyloxapol == | {{Short description|A nonionic liquid polymer used as a surfactant and mucolytic agent}} | ||
{{Drugbox | |||
| verifiedfields = changed | |||
| verifiedrevid = 477002123 | |||
| image = Tyloxapol.png | |||
| image_size = 250px | |||
| image_alt = Chemical structure of Tyloxapol | |||
| image_caption = Chemical structure of Tyloxapol | |||
}} | |||
[[ | '''Tyloxapol''' is a nonionic liquid polymer used primarily as a [[surfactant]] and [[mucolytic agent]]. It is known for its ability to reduce the surface tension of liquids, making it useful in various medical and pharmaceutical applications. | ||
==Chemical Properties== | |||
Tyloxapol is a polymer of the [[alkyl aryl polyether alcohol]] type. It is a viscous liquid that is soluble in water and has a high molecular weight. The chemical structure of Tyloxapol allows it to interact with lipid membranes, which is the basis for its surfactant properties. | |||
== | ==Medical Uses== | ||
Tyloxapol is used in the medical field for its ability to act as a mucolytic agent. It helps in breaking down mucus, making it easier to expel from the respiratory tract. This property is particularly useful in the treatment of conditions such as [[cystic fibrosis]] and [[chronic obstructive pulmonary disease]] (COPD). | |||
Tyloxapol | ===Surfactant Properties=== | ||
As a surfactant, Tyloxapol reduces the surface tension of liquids, which can enhance the dispersion of particles in a solution. This property is utilized in the formulation of various pharmaceutical products, including [[eye drops]] and [[inhalation solutions]]. | |||
== | ===Mucolytic Action=== | ||
Tyloxapol's mucolytic action is due to its ability to disrupt the structure of mucus, decreasing its viscosity and elasticity. This makes it easier for patients to clear mucus from their airways, improving breathing and reducing the risk of infection. | |||
Tyloxapol is | ==Pharmaceutical Applications== | ||
In addition to its use as a mucolytic agent, Tyloxapol is employed in the formulation of [[liposomal]] drug delivery systems. Its surfactant properties help stabilize liposomes, which are used to deliver drugs to specific sites in the body. | |||
==Safety and Side Effects== | |||
Tyloxapol is generally considered safe for use in humans. However, like all medications, it can cause side effects in some individuals. Common side effects include mild irritation of the respiratory tract and allergic reactions in sensitive individuals. | |||
== Safety and | |||
Tyloxapol is generally considered safe for use in humans, | |||
==Related Pages== | |||
* [[Surfactant]] | * [[Surfactant]] | ||
* [[ | * [[Mucolytic agent]] | ||
* [[ | * [[Cystic fibrosis]] | ||
* [[ | * [[Chronic obstructive pulmonary disease]] | ||
[[Category:Surfactants]] | [[Category:Surfactants]] | ||
[[Category:Mucolytics]] | |||
[[Category:Pharmaceuticals]] | [[Category:Pharmaceuticals]] | ||
<gallery> | |||
File:Tyloxapol.png|Tyloxapol | |||
</gallery> | |||
Latest revision as of 01:07, 20 February 2025
A nonionic liquid polymer used as a surfactant and mucolytic agent
| Tyloxapol | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Tyloxapol is a nonionic liquid polymer used primarily as a surfactant and mucolytic agent. It is known for its ability to reduce the surface tension of liquids, making it useful in various medical and pharmaceutical applications.
Chemical Properties[edit]
Tyloxapol is a polymer of the alkyl aryl polyether alcohol type. It is a viscous liquid that is soluble in water and has a high molecular weight. The chemical structure of Tyloxapol allows it to interact with lipid membranes, which is the basis for its surfactant properties.
Medical Uses[edit]
Tyloxapol is used in the medical field for its ability to act as a mucolytic agent. It helps in breaking down mucus, making it easier to expel from the respiratory tract. This property is particularly useful in the treatment of conditions such as cystic fibrosis and chronic obstructive pulmonary disease (COPD).
Surfactant Properties[edit]
As a surfactant, Tyloxapol reduces the surface tension of liquids, which can enhance the dispersion of particles in a solution. This property is utilized in the formulation of various pharmaceutical products, including eye drops and inhalation solutions.
Mucolytic Action[edit]
Tyloxapol's mucolytic action is due to its ability to disrupt the structure of mucus, decreasing its viscosity and elasticity. This makes it easier for patients to clear mucus from their airways, improving breathing and reducing the risk of infection.
Pharmaceutical Applications[edit]
In addition to its use as a mucolytic agent, Tyloxapol is employed in the formulation of liposomal drug delivery systems. Its surfactant properties help stabilize liposomes, which are used to deliver drugs to specific sites in the body.
Safety and Side Effects[edit]
Tyloxapol is generally considered safe for use in humans. However, like all medications, it can cause side effects in some individuals. Common side effects include mild irritation of the respiratory tract and allergic reactions in sensitive individuals.
Related Pages[edit]
-
Tyloxapol
